Eli Lilly Target of New Prozac Lawsuit:...

Eli Lilly Target of New Prozac Lawsuit: Eli Lilly & Co.’s stock price dropped $4.375 a share after news reports of a another lawsuit involving the company’s popular antidepressant drug Prozac. The stock closed at $79.625 after trading was halted temporarily for an order imbalance. Lilly earlier reported one lawsuit seeking damages for alleged ill effects of the drug. The latest suit was filed in Kentucky on behalf of the victims of an incident in Louisville, Ky., where a gunman killed seven people and himself. The suit alleges that the gunman was taking Prozac. Lilly officials could not be reached for comment.